Article abstract
Nature Medicine 15, 901 - 906 (2009)
Published online: 17 May 2009 | doi:10.1038/nm.1967
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
Philip R Johnson1, Bruce C Schnepp1, Jianchao Zhang2, Mary J Connell1, Sean M Greene1, Eloisa Yuste3, Ronald C Desrosiers3 & K Reed Clark2
Abstract
The key to an effective HIV vaccine is development of an immunogen that elicits persisting antibodies with broad neutralizing activity against field strains of the virus. Unfortunately, very little progress has been made in finding or designing such immunogens. Using the simian immunodeficiency virus (SIV) model, we have taken a markedly different approach: delivery to muscle of an adeno-associated virus gene transfer vector expressing antibodies or antibody-like immunoadhesins having predetermined SIV specificity. With this approach, SIV-specific molecules are endogenously synthesized in myofibers and passively distributed to the circulatory system. Using such an approach in monkeys, we have now generated long-lasting neutralizing activity in serum and have observed complete protection against intravenous challenge with virulent SIV. In essence, this strategy bypasses the adaptive immune system and holds considerable promise as a unique approach to an effective HIV vaccine.
- The Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
- The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
- New England Primate Research Center and Harvard Medical School, Southborough, Massachusetts, USA.
Correspondence to: Philip R Johnson1 e-mail: johnsonphi@chop.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Blocking and tackling HIVNature Medicine News and Views (01 Aug 2009)
HIV?1 neutralizing antibodies: How full is the bottle?Nature Medicine News and Views (01 Feb 1999)
See all 8 matches for News And ViewsRESEARCH
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodiesNature Medicine Article (01 Feb 2000)
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian?human immunodeficiency virus infectionNature Medicine Article (01 Feb 2000)
See all 59 matches for Research
